Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcome of patients with low-risk and intermediate-1-risk myelodysplastic syndrome after hypomethylating agent failure: a report on behalf of the MDS Clinical Research Consortium.
Jabbour EJ, Garcia-Manero G, Strati P, Mishra A, Al Ali NH, Padron E, Lancet J, Kadia T, Daver N, O'Brien S, Steensma DP, Sekeres MA, Gore SD, Dezern A, Roboz GJ, List AF, Kantarjian HM, Komrokji RS. Jabbour EJ, et al. Among authors: padron e. Cancer. 2015 Mar 15;121(6):876-82. doi: 10.1002/cncr.29145. Epub 2014 Nov 19. Cancer. 2015. PMID: 25410759 Free PMC article.
Biology and treatment of the 5q- syndrome.
Padron E, Komrokji R, List AF. Padron E, et al. Expert Rev Hematol. 2011 Feb;4(1):61-9. doi: 10.1586/ehm.11.2. Expert Rev Hematol. 2011. PMID: 21322779 Review.
The 5q- syndrome: biology and treatment.
Padron E, Komrokji R, List AF. Padron E, et al. Curr Treat Options Oncol. 2011 Dec;12(4):354-68. doi: 10.1007/s11864-011-0165-1. Curr Treat Options Oncol. 2011. PMID: 21964863
Advances in the management of myelofibrosis.
Komrokji RS, Verstovsek S, Padron E, List AF. Komrokji RS, et al. Among authors: padron e. Cancer Control. 2012 Oct;19(4 Suppl):4-15. doi: 10.1177/107327481201904s04. Cancer Control. 2012. PMID: 23042420 Free article. Review.
Prognostic factors and risk models in myelodysplastic syndromes.
Komrokji RS, Padron E, Lancet JE, List AF. Komrokji RS, et al. Among authors: padron e. Clin Lymphoma Myeloma Leuk. 2013 Sep;13 Suppl 2:S295-9. doi: 10.1016/j.clml.2013.05.022. Clin Lymphoma Myeloma Leuk. 2013. PMID: 24290214 Review.
260 results